How to Read a Peptide Certificate of Analysis (COA) in 2026

For in-vitro laboratory research use only. Not for human consumption.

A research peptide is only as well characterized as the documentation that accompanies it. In 2026, laboratories buying synthetic peptides have to read analytical reports critically: what each test measures, what conditions it was run under, and what the resulting number does and does not tell them. This guide walks through each section of a typical Certificate of Analysis, explains the analytical methods behind the figures, and sets out the questions worth asking about any document of this kind.

What a COA Should Contain

A complete peptide COA includes the following at minimum:

• Compound name and full sequence — written in standard amino acid notation, with any modifications stated
• Molecular formula and theoretical molecular weight — the reference values for identity confirmation
• Appearance — usually a description such as "white lyophilized powder"
• Chromatographic purity by HPLC — with the column, gradient and detection wavelength stated
• Identity confirmation (LC-MS or FTIR) — the observed mass alongside the theoretical mass (LC-MS), or a spectral match to a reference (FTIR)
• Net peptide content — the fraction of the powder's mass that is peptide
• Water content — typically by Karl Fischer titration
• Counter-ion identity and content — commonly acetate or trifluoroacetate
• Storage conditions — the recommended temperature for the lyophilized material
• A reference to the material analyzed — a sample or reference number that links the document to the product
• Signature and date — the analyst or reviewer who approved the data

HPLC Purity: The Core Composition Metric

High-performance liquid chromatography (HPLC) is the standard method for assessing the chromatographic purity of a synthetic peptide. A useful report includes:

• A chromatogram with a clearly resolved primary peak
• The purity percentage, calculated as the main peak area divided by the total area of all peaks
• The method conditions: column type and dimensions, mobile phase composition, gradient and detection wavelength
• The retention time of the main peak

Without the method conditions, a purity percentage cannot be interpreted or reproduced, because the figure depends on the column, the gradient, the detection wavelength and the integration settings. Two laboratories analyzing the same material with different methods can legitimately report different numbers.

Identity Confirmation: Mass Spectrometry or FTIR

HPLC indicates how much of the detected material is one compound; an identity test indicates whether that compound is the intended molecule. For mass spectrometry (LC-MS), the report should state the theoretical molecular weight calculated from the sequence and the observed mass, and the two should agree within the instrument's stated tolerance. For longer peptides the observed value is derived by deconvoluting a series of multiply charged ions. For FTIR, the report states whether the sample's infrared spectrum matches the reference spectrum for the compound; the backbone amide bands and side-chain absorptions give each peptide a characteristic fingerprint.

A document that reports a purity figure without any identity confirmation leaves the identity of the material unestablished, because an unrelated compound can elute at a similar retention time. Conversely, an identity result without chromatographic data says nothing about how much of the sample is the target peptide. The two analyses answer different questions and are needed together.

Independent Analytical Testing

In-house testing has an obvious incentive problem. Documentation carries more weight when the analysis was performed by an accredited laboratory with no commercial interest in the outcome. Useful features of such a report include:

• A testing laboratory name distinct from the supplier
• Accreditation references where applicable, such as ISO/IEC 17025
• The methods and instrument types used
• A reference number linking the report to the material analyzed

A laboratory can also commission its own analysis of incoming material, which is the most direct way to establish what it is working with. This is particularly worthwhile where the work is sensitive to composition, or where a study depends on a defined specification for the specific vial in use.

Traceability: Which Material Was Analyzed

A COA should make clear which material the analysis refers to: the compound name, the sample or lot reference, and the dates the sample was received and reported. Many reports also carry an accession number or search code that can be entered on the laboratory's own lookup page to retrieve the same document. Either way, a reader should check that the compound named matches the product, note the reference for the laboratory record, and verify incoming material independently if the work depends on a defined specification.

Questions Worth Asking About Any COA

• Are the method conditions stated for every reported figure?
• Is there an identity confirmation, not just a purity figure?
• Does the document state what material was analyzed, and when?
• Are net peptide content, water content and counter-ion content reported, so the mass balance is complete?
• Was an endotoxin measurement performed, if the material is intended for cell-based work?
• Is the analysis in-house or independent, and is the laboratory named?
• Are storage conditions stated?

Documentation from Excalibur Peptides

Excalibur Peptides is a U.S.-based research peptide supplier. All 18 products are third-party tested; each product's COA is published in our COA database and on the relevant product page. Purity is measured by HPLC for every product, and identity by LC-MS, at Freedom Diagnostics Testing. Each certificate names the laboratory that issued it and records the analysis of a sample of that product, with the sample reference stated; it does not describe the specific vial a laboratory receives. Each certificate carries a reference, a search code, for looking it up with the laboratory. Laboratories whose work depends on a defined specification should record the COA reference and include their own incoming HPLC and identity analysis in their procedures.

All products sold by Excalibur Peptides are intended for in-vitro laboratory research use only. Not for human consumption.

The Significance of Ancillary Testing: Beyond Composition and Identity

While HPLC and identity testing (LC-MS or FTIR) are the cornerstones of a peptide COA, they do not provide a complete picture of the research material's quality. For rigorous, reproducible in-vitro studies, especially those involving sensitive cell cultures or quantitative binding assays, several ancillary tests add useful information. Where these data points are not reported on the documentation, a laboratory can ask whether they are available or commission the analyses itself, since they support accurate interpretation of experimental results.

Net Peptide Content: How Much of the Powder Is Peptide

This is one of the most misunderstood parameters on a detailed COA. It is easy to assume that a chromatographic purity figure describes the contents of the vial by mass. It does not.

• Chromatographic purity measures the target peptide as a percentage of the total peptide-related material detected by the UV detector. It is a measure of the success of the synthesis and purification, and it says nothing about non-peptide components.

Therefore, a vial of lyophilized powder contains:

1. The desired peptide.
2. Counter-ions (e.g., TFA, Acetate).
3. Bound water.
4. Trace peptide-related impurities.

Net peptide content analysis, typically performed by quantitative amino acid analysis (AAA) or calculated from nitrogen content, determines the percentage of the powder's mass that is peptide. The value is routinely well below 100 percent, because counter-ions and bound water make up the remainder, and it is lower for basic peptides, which bind several counter-ion equivalents.

Why this matters: If a mass of powder is weighed and assumed to be entirely peptide, the resulting concentration is overestimated by exactly the non-peptide fraction, and that error propagates through every subsequent dilution. Using the net peptide content converts a weighed mass into an actual quantity of peptide:

• Corrected Mass = (Mass Weighed) x (Peptide Content Percentage)

Only by using this corrected mass can a researcher prepare stock solutions of a known, accurate concentration for their in-vitro assays.

Moisture Content (Karl Fischer Titration)

Directly related to peptide content, moisture content analysis quantifies the amount of water present in the lyophilized sample. The industry-standard method is Karl Fischer (KF) titration, a highly accurate coulometric or volumetric technique that selectively reacts with water.

A peptide's stability is intrinsically linked to its water content. While lyophilization (freeze-drying) removes the vast majority of water to create a stable powder for shipping and storage, some residual moisture is always present. High moisture content (>10%) can:

• Promote hydrolysis of labile peptide bonds over time, reducing shelf-life even when stored frozen.
• Contribute to the non-peptide mass of the powder, further confounding accurate weighing for experimental stock solutions.

A complete COA lists a specific water content determined by Karl Fischer titration. A low value indicates effective freeze-drying and appropriate packaging; a high value suggests moisture uptake, which both inflates the non-peptide mass and accelerates hydrolysis during storage.

Endotoxin Analysis (LAL Assay)

This test is particularly relevant for research involving cell-based assays. Endotoxins, also known as lipopolysaccharides (LPS), are fragments of the outer membrane of Gram-negative bacteria. They are potent inflammatory pyrogens. Even infinitesimal quantities of endotoxin can trigger strong, non-specific responses in immune cells (like macrophages and monocytes) and can affect the viability, proliferation, and signaling pathways of many other cell types in-vitro.

If a researcher is measuring a cytokine response, a phosphorylation event or a transcript level in cultured cells, endotoxin contamination in any reagent can dominate the readout. Because endotoxins activate Toll-like receptor 4 signaling at very low concentrations, and TLR4 is expressed on many cell types besides immune cells, an endotoxin value on the documentation is what lets a laboratory exclude the peptide preparation as a source of such an artifact.

The standard method for detection is the Limulus Amebocyte Lysate (LAL) test, which uses a protein extract from the blood of the horseshoe crab (Limulus polyphemus). This lysate coagulates in the presence of minute amounts of endotoxin. The COA should specify the result in Endotoxin Units per milligram (EU/mg). For research involving cell culture, the acceptable limit is typically very low, often <0.1 EU/mg, and ideally even lower (<0.01 EU/mg). For cell-based work an endotoxin value is useful; where none is reported on the documentation, laboratories can run the LAL test themselves or through an analytical service before the material is used in sensitive assays.

A Deeper Look at Analytical Techniques

Understanding how the data on a COA is generated provides researchers with a greater capacity to critically evaluate its quality. The instrumentation and methodologies used are as important as the final numbers themselves.

The Mechanism of High-Performance Liquid Chromatography (HPLC)

Think of HPLC as an automated, highly precise form of column chromatography. For peptides, the most common mode is Reverse-Phase HPLC (RP-HPLC).

1. The Stationary Phase: The inside of the chromatography column is packed with silica particles that have been chemically modified with long hydrocarbon chains, most commonly 18 carbons long (a "C18" column). This creates a non-polar, hydrophobic stationary phase.
2. The Mobile Phase: Two solvents are used: one is highly polar (Mobile Phase A, typically deionized water with a small amount of an ion-pairing agent like TFA), and the other is less polar/more organic (Mobile Phase B, typically acetonitrile with TFA).
3. The Separation: The peptide sample, dissolved in a small amount of liquid, is injected into the system. It first encounters a mobile phase that is mostly water (polar). Since the C18 column is non-polar, the peptides, which have both polar and non-polar characteristics, will "stick" to the stationary phase with varying affinities. More hydrophobic peptides will stick more strongly.
4. The Gradient: The instrument then begins to change the solvent composition over time, gradually increasing the percentage of the organic solvent (acetonitrile). This is called a "gradient." As the mobile phase becomes more non-polar, it becomes better at "dissolving" the peptides off the non-polar column.
5. Elution and Detection: Less hydrophobic peptides (or smaller ones) will be dislodged first and travel through the column faster. More hydrophobic peptides will hold on longer and elute later. As the separated compounds exit the column, they pass through a detector—typically a UV-Vis detector set to a wavelength of 214nm or 220nm, which is strongly absorbed by the peptide bonds in the backbone of the molecule. Each compound that elutes generates a "peak" on the chromatogram.
6. The Result: The resulting chromatogram shows peaks over time. The time it takes for a peak to appear (retention time) is characteristic of that molecule under those specific conditions. The area under the peak is proportional to the concentration of that molecule. HPLC Purity is calculated by dividing the area of the main peptide peak by the total area of all detected peaks.

A well-executed HPLC method shows a sharp, symmetrical main peak, indicating a well-resolved compound, and a flat baseline. Peak shoulders, poor resolution between the main peak and a neighbouring impurity, or a rising baseline all limit what the reported figure can support, which is another reason the chromatogram itself is more informative than the number alone.

Dissecting the Mass Spectrometry Report

Mass Spectrometry (MS) does not measure purity; it measures mass-to-charge ratios (m/z) and provides definitive structural confirmation. For peptides, the most common technique is Electrospray Ionization Mass Spectrometry (ESI-MS).

1. Ionization (ESI): The peptide solution eluted from the HPLC (or injected directly) is sprayed through a fine, charged needle at the entrance of the mass spectrometer. The strong electric field creates a fine mist of charged droplets. As the solvent evaporates, the charge density on the droplets increases until the peptide molecules are ejected as gas-phase ions, often carrying multiple positive charges (protons) from acidic residues or the analytical solvent. For example, a peptide might be observed as `[M+2H]2+` or `[M+3H]3+`, where M is the mass of the neutral molecule.
2. Mass Analysis: These ions are guided into a mass analyzer, such as a Time-of-Flight (TOF) or Quadrupole analyzer.
   • TOF Analyzer: Ions are accelerated by an electric field and allowed to drift through a field-free tube. Lighter ions (lower m/z) travel faster and hit the detector first. The instrument measures the precise time it takes for ions to travel the length of the tube, which is then used to calculate their m/z with very high accuracy.
   • Quadrupole Analyzer: This uses four parallel rods to create an oscillating electromagnetic field that only allows ions of a specific m/z to pass through to the detector at any given moment. By scanning through a range of field settings, a full mass spectrum can be generated.
3. The Spectrum: The output is a plot of relative intensity versus m/z. For a pure peptide, this spectrum will show a characteristic pattern of peaks, representing the molecule with different charge states (e.g., the `[M+2H]2+`, `[M+3H]3+`, `[M+4H]4+` series). Software can "deconvolute" this series to calculate the original, uncharged molecular weight (M) of the parent molecule.
4. Verification: This experimentally determined molecular weight is then compared to the theoretical molecular weight, which is calculated based on the peptide's amino acid sequence. A match within a very narrow tolerance (e.g., +/- 0.5 Daltons) provides powerful evidence that the primary component detected by HPLC is indeed the correct peptide sequence.

A COA that states an identity result such as "Confirmed" should name the method used, for example LC-MS or FTIR. Where a mass spectrometry report also lists the observed and theoretical masses, the two numbers, together with the instrument type, let a reader judge the match directly and spot the characteristic mass differences that indicate oxidation, deamidation or an incomplete modification.

The Journey to a Validated Vial: Sourcing and Logistics

The quality documented on a COA is the end result of a long and complex chain of custody, beginning with chemical synthesis, continuing through storage before dispatch, and ending with delivery to the research laboratory. Gaps in this chain can invalidate an otherwise perfect COA.

Solid-Phase Peptide Synthesis (SPPS) and Its Impurities

The vast majority of research peptides are produced via Solid-Phase Peptide Synthesis (SPPS). Understanding this process helps a researcher appreciate the types of impurities that HPLC is designed to detect. In SPPS, the peptide is built one amino acid at a time while anchored to a solid resin bead. The cycle involves:

1. Deprotection: Removing a temporary protecting group from the last amino acid added.
2. Coupling: Activating and attaching the next protected amino acid in the sequence.
3. Washing: Rinsing away excess reagents.

This cycle is repeated until the full sequence is assembled. In reality, none of these steps are 100% efficient. This leads to predictable impurity profiles:

• Deletion Sequences: If a coupling step fails, the final peptide will be missing one amino acid.
• Truncation/Capped Sequences: If the deprotection step fails, the chain stops growing prematurely. Sometimes the unreacted end is intentionally "capped" to prevent it from reacting further.
• Impurities from Protecting Groups: Residual chemical fragments from the protecting groups used during synthesis can remain attached to the peptide.
• Racemization: The chemical conditions can sometimes cause an L-amino acid to convert to its D-amino acid mirror image, resulting in a diastereomeric impurity that can be difficult to separate.

After synthesis, the crude peptide is cleaved from the resin and purified, almost always using preparative HPLC. The goal of this large-scale purification is to separate the full-length, correct peptide from this complex mixture of synthesis-related failures. The analytical HPLC data on the final COA is a direct confirmation of how successful this purification was. Whatever figure a COA reports, the remainder of the detected peptide material consists of these failed sequences, whose behaviour in a sensitive in-vitro system is unknown, which is why the chromatogram and the method conditions matter as much as the number itself.

Storage: Preserving Integrity from Lab to Lab

A peptide's journey does not end after it passes final QC testing. Peptides, particularly in their lyophilized state, are sensitive to temperature, humidity, and light. The longest stretches of a vial's life are spent in storage, first at the supplier and then in the receiving laboratory, and cold, dry storage at both ends is what maintains its stability.

• Lyophilization for Stability: Peptides are lyophilized (freeze-dried) because removing water makes them far more stable than they would be in solution.
• Transit Time: More stable does not mean indestructible. Prolonged exposure to high heat (e.g., sitting in a hot delivery truck for days) can still cause degradation, particularly for complex sequences or those with sensitive residues like Methionine or Cysteine. Shorter transit times and prompt unpacking on arrival limit this exposure, so transit time is worth considering when choosing a shipping option.
• Upon Arrival: The researcher's responsibility for storage begins at this point. The product page lists the storage temperature for the sealed vial. Leaving a newly arrived vial on a lab bench for a week before storing it properly can compromise its integrity, regardless of how good the COA was on the day of testing. The data on the COA is only valid if the material has been handled and stored correctly throughout its entire lifecycle.

A supplier's approach to temperature control is reflected in how it stores material before dispatch, for example frozen storage of recently made batches, and in the storage conditions listed for the product. A laboratory can reasonably ask how material is stored before dispatch and what conditions are recommended on arrival, and can record the condition of each package on receipt as the first entry in the material's own history.

Comparing Documentation Across Products

Analytical documents differ in what they can support, and knowing the difference matters when planning work. Three situations are common across research suppliers generally.

A Certificate of Analysis commissioned by the supplier. The document names the testing laboratory and the supplier as its client, and records analysis of a sample of that product with method conditions and the analyzed lot or sample reference stated. It is highly informative for understanding the product's analytical profile, but it does not necessarily describe the specific vial a laboratory receives. The sensible practice is to record the COA reference in the laboratory notebook, check the method conditions, and run incoming HPLC and identity testing where the work is sensitive to composition.

A certificate issued through a verification service. Some services submit blind-coded samples of a product to an independent laboratory and publish the result under a certificate ID that anyone can check online; the report lists the service as the customer and uses the certificate ID as the lot. It records the analysis of a sample of that product just as a supplier-commissioned COA does, with the added step of public verification. The sensible practice is the same: verify the certificate ID, record it, and run incoming analysis where the work is sensitive to composition.

No available Certificate of Analysis. Some compounds offered in the research market have no published analytical document at all. Here the laboratory is the only source of characterization data, so incoming HPLC and identity testing become part of the experimental record rather than an optional extra.

The practical implication is the same in all three cases: the methods section of any report should state what documentation existed and what analysis the laboratory performed itself. That distinction is what allows another group to judge how well characterized the material was.

For research use only: every compound discussed in this article is a chemical reagent supplied for in-vitro laboratory research. None is approved for human use.

Expanded Frequently Asked Questions (FAQ) for Researchers

Q1: A COA reports a high chromatographic purity but a considerably lower net peptide content. Is the peptide impure? The two values measure different things and are not contradictory. Chromatographic purity describes what proportion of the peptide-related material detected by the UV detector is the correct, full-length sequence. Net peptide content describes what proportion of the total powder mass is peptide at all. The remainder consists of counter-ions from purification and bound water, both of which are expected components of a lyophilized peptide salt. A material can therefore be chromatographically clean and still contain a substantial non-peptide fraction by mass. Quantitative calculations use the net peptide content; assessments of synthesis quality use the chromatographic figure.

Q2: What is TFA (Trifluoroacetic Acid) and why is it mentioned on some COAs? TFA is a strong acid commonly used during both the cleavage of the peptide from the synthesis resin and as an ion-pairing agent in reverse-phase HPLC purification. As a result, the final lyophilized peptide is often a TFA salt. High residual TFA can be cytotoxic in some sensitive cell culture assays. Some suppliers use purification methods designed to minimize residual TFA, and some documents report a quantitative value for it, often as a percentage determined by ion-exchange chromatography. If your in-vitro model is particularly sensitive, you may want to look for peptides purified and supplied as acetate salts, which is a more biocompatible alternative, though sometimes more difficult to produce.

Q3: The theoretical mass is 4117.6 Da but the observed mass on the MS report is 4118.0 Da. Is this a problem? No, this is typical and indicates a good match. Mass Spectrometers have a certain mass accuracy. For a standard ESI-MS instrument, a resolution within +/- 0.5 Daltons (Da) of the theoretical mass is generally considered a successful confirmation of identity for a peptide of this size. High-resolution instruments like TOF or Orbitrap mass spectrometers can achieve much higher accuracy (into the parts-per-million or ppm range), but for routine QC, a match within a fraction of a Dalton is sufficient evidence.

Q4: Why doesn't a COA include a bioactivity or functional assay result? A standard analytical certificate documents chemistry, not biology: identity, composition, water, counter-ion and, where performed, endotoxin. Functional activity depends on the assay, the cell line, the receptor expression level and many other variables that the supplier cannot control, so a single activity figure would not transfer between laboratories. Establishing that a compound behaves as expected in a particular system is the laboratory's own work, and it is why a reference ligand is run alongside a test compound in every experiment.

Q5: The COA test date is several months old. What does that date tell a laboratory? The test date records when the analysis was performed, and nothing more. The analysis describes the sample the laboratory received, identified by the sample or lot reference on the document, so the first step is to note that reference. The date does not describe the current condition of any particular vial. The condition of lyophilized material depends on its storage history since analysis: temperature, exposure to moisture and light, and how often a container has been opened. Recording the date of receipt and the storage conditions, and running an incoming HPLC and identity check where an application is sensitive, gives a laboratory direct evidence rather than an inference from the date.

Q6: What does "HPLC chromatogram: shows a single major peak" mean when the purity figure is below 100 percent? It refers to the visual appearance of the trace. The remaining material is usually distributed across several very small peaks near the baseline, which are not obvious unless the y-axis is expanded. The phrase is therefore a description rather than a measurement, and the reported area percentage is the quantitative statement. When the distribution of impurities matters, the chromatogram itself, with an expanded baseline, is more informative than either the phrase or the single number.

Q7: Can a COA be reviewed before purchase? Yes. All 18 products are third-party tested; each product's COA is published in the COA database and on the relevant product page, so the documentation can be read before ordering. Each COA names the testing laboratory (Freedom Diagnostics Testing) and the identity method used (LC-MS), which is worth noting for work that requires a defined specification.

Q8: What if a product arrives and its documentation appears to be missing or incorrect? Contact our support team at info@excaliburpeptides.com with the order number and the identifier printed on the vial. Each product's published certificate is also available in the COA database and on the relevant product page, so a document can be checked independently at any time. Each certificate can be looked up on the testing laboratory's own site with the search code printed on it; a laboratory that needs a specification for the specific vial in use should plan for its own incoming analysis.

Glossary of Key Terms

• Aliquot: A portion divided from a larger volume for single use, which avoids repeated freeze-thaw cycles.
• Amino Acid Analysis (AAA): Hydrolysis of a peptide followed by separation and quantification of the liberated amino acids; the standard method for net peptide content.
• Chromatogram: The output of a chromatographic run, plotting detector response against time.
• Counter-ion: An ion accompanying a charged peptide to maintain electrical neutrality, commonly acetate or trifluoroacetate from purification.
• Deamidation: Conversion of an asparagine or glutamine side chain to its acidic form, adding about 1 Da to the peptide mass.
• Deconvolution: Conversion of a series of multiply charged ions in a mass spectrum into a single neutral molecular mass.
• Deletion Sequence: A synthesis by-product missing one or more residues from the intended sequence.
• Endotoxin: A lipopolysaccharide from the outer membrane of Gram-negative bacteria, measured by the LAL assay.
• ESI (Electrospray Ionization): A soft ionization technique producing intact, often multiply charged ions from molecules in solution.
• Gradient Elution: Progressive change of mobile-phase composition during a chromatographic run to elute compounds in order of their interaction with the stationary phase.
• HPLC: High-performance liquid chromatography, the standard method for assessing the chromatographic purity of a peptide.
• ISO/IEC 17025: An international standard for the competence of testing and calibration laboratories.
• Karl Fischer Titration: A specific titration method for determining water content.
• Lyophilization: Freeze-drying, which removes water by sublimation under vacuum to give a stable powder.
• Mass Spectrometry (MS): Measurement of the mass-to-charge ratio of ions, used to confirm molecular weight and identity.
• MS/MS: Tandem mass spectrometry, in which a selected ion is fragmented to confirm the sequence and localize modifications.
• Net Peptide Content: The proportion of a lyophilized powder's mass that is peptide rather than counter-ions and water.
• Racemization: Partial conversion of an L-amino acid to its D form during synthesis, producing a diastereomer of identical mass.
• Retention Time: The time at which a compound elutes from a chromatographic column under defined conditions.
• Reversed-Phase HPLC: Chromatography on a nonpolar stationary phase with a polar mobile phase, the standard mode for peptides.
• Scavenger: A reagent added during cleavage from the synthesis resin to trap reactive species and protect sensitive residues.
• System Suitability: A set of criteria, such as peak symmetry and resolution, demonstrating that a chromatographic method is performing as intended.

References

• Behrendt R, White P, Offer J. J Pept Sci. 2016;22(1):4-27.
• Merrifield RB. J Am Chem Soc. 1963;85(14):2149-2154.
• Snyder LR, Kirkland JJ, Dolan JW. Introduction to Modern Liquid Chromatography. 3rd ed. Wiley; 2010.
• Mant CT, Chen Y, Yan Z, Popa TV, Kovacs JM, Mills JB, et al. Methods Mol Biol. 2007;386:3-55.
• Hancock WS, Sparrow JT. J Chromatogr. 1981;206(1):71-82.

For in-vitro laboratory research use only. All products and information provided are not for human or veterinary use. The compounds sold by Excalibur Peptides are chemical reagents intended solely for laboratory and developmental applications. It is the researcher's responsibility to ensure proper handling, storage, and use of these materials in accordance with established laboratory safety protocols.

Advanced Impurity Profiling: What HPLC Might Miss

While HPLC is excellent for quantifying purity based on peptide-related impurities, certain types of impurities are subtle and require careful method development to detect. Their presence can significantly impact in-vitro results, making their characterization crucial for high-level research. A truly comprehensive analytical report may comment on these potential issues.

Deamidation

Amino acids with side-chain amides, namely Asparagine (Asn) and Glutamine (Gln), are susceptible to a chemical process called deamidation. Under certain pH and temperature conditions, especially in aqueous solution, the side-chain amide group can be hydrolyzed into a carboxylic acid. This converts Asn to Aspartic Acid (Asp) and Gln to Glutamic Acid (Glu). This introduces a new negative charge to the peptide at physiological pH, which can drastically alter its three-dimensional conformation, receptor binding affinity, and solubility. Deamidation is a common degradation pathway, and its rate is highly sequence-dependent. An HPLC method must be optimized to resolve the slightly more acidic deamidated peptide from the parent peptide. Mass spectrometry can confirm this change, as the conversion adds approximately 1 Dalton to the total mass.

Oxidation

Residues like Methionine (Met), Cysteine (Cys), and Tryptophan (Trp) are prone to oxidation. The sulfur atom in Methionine is particularly susceptible, converting to methionine sulfoxide. This adds 16 Da to the molecular weight and increases the peptide's polarity, which can decrease its biological activity in receptor binding assays. This change is readily detectable by HPLC (as an earlier-eluting peak) and confirmed by mass spectrometry. For any peptide containing these sensitive residues, it is a key quality attribute to check, as improper handling or storage (e.g., exposure to air/light) can accelerate this process. A low percentage of oxidized species on a COA indicates high-quality synthesis and handling.

Racemization and Diastereomers

Amino acids (except glycine) are chiral molecules, existing in either an L- or D-isoform. Biological systems almost exclusively use L-amino acids. During the chemical steps of solid-phase peptide synthesis, the harsh conditions can sometimes cause an L-amino acid to "racemize," or convert into its D-form. This results in a peptide molecule that has the correct sequence and mass but an incorrect stereochemistry at one position. This kind of impurity is called a diastereomer. Diastereomers can be exceptionally difficult to separate from the parent L-peptide using standard HPLC methods, yet they can have dramatically different (or zero) biological activity. Detecting and quantifying these requires specialized chiral chromatography techniques, which are not typically part of a standard COA but represent the pinnacle of peptide analytical chemistry.

Laboratory Handling of the Lyophilized Material

A well-characterized peptide is only useful if it is handled so that the material in an experiment still matches its documentation. The practices below concern the dry, lyophilized powder and the records kept about it.

Receiving and Recording

Inspect each vial for an intact seal and cap, legible labeling and a dry, uniform powder of the expected appearance. Confirm that the product name and any reference number match the documentation on file, then log the date received, quantity, package condition, storage location and documentation reference. This record is what later links an experiment to a specific material.

Storage of the Dry Powder

1. Temperature: Store sealed vials at -20°C, or -80°C for extended archiving, in a manual-defrost freezer, since frost-free units periodically warm to remove ice.
2. Moisture: Lyophilized peptides are hygroscopic. Keep vials sealed and, where practical, inside a secondary container with desiccant.
3. Light and Air: Keep vials in their carton. This matters most for peptides containing methionine, cysteine or tryptophan, the residues most prone to oxidation.
4. Monitoring: A freezer temperature log or monitoring device documents that conditions held through a project.

Opening and Weighing

1. Equilibration: Allow the sealed vial to reach room temperature for 20 to 30 minutes before opening. Opening a cold vial lets humid air condense on the powder, which adds an unknown mass of water and compromises both accuracy and stability.
2. Centrifugation: Briefly centrifuge the sealed vial so that any powder dislodged in transit collects at the bottom before the cap is removed.
3. Balance and static control: Use a calibrated microbalance with an antistatic device. Lyophilized powders are light and prone to static, and hydrophobic peptides cling to weighing vessels.
4. Speed and resealing: Work quickly in low humidity and reseal the vial promptly, minimizing the time it stands open.
5. Calculation basis: Convert the weighed mass to peptide mass using the net peptide content and water content from the documentation, or from the laboratory's own analysis.

Protective Equipment, Records and Disposal

Wear gloves, a lab coat and eye protection, and weigh fine powders in a draft-shielded enclosure. Hazard and disposal information is available on our Safety Data Sheets page. Log each opening of a vial and the quantity removed, and dispose of expired or unneeded material through institutional chemical waste procedures in accordance with local regulations.

Preparing Analytical Samples

When material is taken for analysis rather than storage, a few points preserve the integrity of both the sample and the remaining stock. Use clean, low-binding vessels, since peptides adsorb to some plastics at low concentrations. Prepare analytical solutions in solvents compatible with the intended method, keeping in mind that trifluoroacetic acid suppresses ionization in mass spectrometry, so formic acid is generally preferred for LC-MS while trifluoroacetic acid gives sharper peaks for UV-detected HPLC. Record the solvent, the concentration, the date of preparation and the storage conditions of any analytical solution alongside the resulting data, and note whether a solution has been frozen and thawed, since that history is part of the interpretation of any chromatogram.

The Role of Gas Chromatography in Evaluating Residuals

While liquid chromatography (HPLC) is perfect for analyzing the non-volatile peptide itself, a complete quality assessment must also investigate the volatile and semi-volatile compounds that might remain from the synthesis process. This is the domain of Gas Chromatography (GC), often coupled with a Mass Spectrometer (GC-MS).

This analysis is critical for ensuring that residual solvents used during synthesis or peptide cleavage (e.g., Dichloromethane (DCM), Diethyl ether, Acetonitrile) are below acceptable levels for research applications. Many of these solvents can be cytotoxic, even at trace concentrations, and could interfere with sensitive in-vitro assays.

In a typical GC analysis for residual solvents:

1. A sample of the lyophilized peptide is dissolved in a suitable high-boiling-point solvent (like DMSO or DMF).
2. This solution is injected into the gas chromatograph, where it enters a heated chamber, causing the volatile solvents to flash-vaporize.
3. An inert carrier gas (like helium or nitrogen) sweeps these vaporized solvents into a long, thin capillary column. The column's inner walls are coated with a stationary phase.
4. Separation occurs based on the boiling points and polarities of the residual solvents. More volatile compounds travel faster through the column.
5. As each solvent exits the column, it is detected, often by a Flame Ionization Detector (FID) or a Mass Spectrometer, which can positively identify the compound by its mass spectrum.

A COA that includes a section on residual solvents, specifying that they are "Not Detected" or below a defined ppm (parts-per-million) threshold, provides an additional layer of confidence that the material is free from potentially confounding process contaminants.

Summary Table: Key Analytical Techniques for Peptide Validation

This table summarizes the purpose of each major analytical test discussed. A trustworthy COA for high-level research should include data from most, if not all, of these techniques.

Advanced Researcher FAQ

Q1: I see "Appearance: White Lyophilized Powder" on the COA. What if mine is flaky, crystalline, or a bit clumpy? The physical appearance of lyophilized material can vary significantly depending on the peptide sequence, concentration during lyophilization, and the process parameters used. It can range from a dense, collapsed "cake" at the bottom of the vial to a fluffy, crystalline solid, or even a thin, hard-to-see film. All of these are normal. The critical parameters are the ones measured analytically (HPLC purity, identity by LC-MS or FTIR, peptide content), not the visual appearance of the powder itself. As long as it is a dry solid, its appearance is not an indicator of poor quality.

Q2: What is ISO/IEC 17025 accreditation, and why does it matter for a testing laboratory? ISO/IEC 17025 is an international standard for the technical competence of testing and calibration laboratories. Accreditation means an external body has assessed the laboratory's methods, equipment calibration, staff training, quality systems and participation in proficiency testing. For a reader of a Certificate of Analysis, it provides assurance that the methods behind the figures were validated and that the measurements are traceable, which matters most when comparing documents from different sources or resolving a discrepancy between a supplier's data and a laboratory's own analysis.

Q3: Can I use UV-Vis spectrophotometry (like a NanoDrop) to quantify a peptide in solution? While this is possible, it should be done with caution. Using absorbance at 280 nm (A280) is only effective for peptides containing Tryptophan (Trp) or Tyrosine (Tyr) residues, and the exact extinction coefficient must be known for that specific sequence. Using absorbance at 214 nm is more general (measures the peptide backbone) but is highly susceptible to interference from other substances, including TFA counter-ions and some buffers. For quantification, weighing combined with the net peptide content reported on a COA is generally more reliable than UV absorbance at 214 nm.

Q4: Does a peptide stay stable in a refrigerated autosampler during a long HPLC sequence? This is highly sequence-dependent, and no general time window applies. Peptides with sensitive residues (Met, Cys, Asn, Gln) or those in non-optimal pH buffers can begin to degrade (oxidize, deamidate) even at 4°C over a long sequence. For long-running, quantitative experiments, it is best practice to perform a stability test by reinjecting the same standard at the beginning and end of the sequence to check for any degradation.

Q5: The mass spectrum shows a peak for [M+Na]+. What is that? It is a sodium adduct: a sodium ion has associated with the neutral peptide instead of a proton, giving a species about 22 Da heavier than the protonated molecule. Sodium is ubiquitous in glassware, buffers and solvents, so adducts of this kind are common and are not a sign of a problem with the peptide. Potassium adducts appear about 38 Da heavier. Recognizing adducts prevents them from being misread as modifications, and reducing salt in the sample, for example by using volatile buffers, lowers their intensity.

Q6: The HPLC run on a COA is only 15 minutes. Is that long enough? It can be, provided the method has been shown to resolve the relevant impurities and that nothing elutes after the recorded window. The two things worth checking are whether the gradient reaches a high enough organic content to elute strongly retained species, and whether the run includes a hold at high organic content to wash the column. A short method for a small, polar peptide may be entirely adequate, while a lipidated peptide typically needs a longer run. If the report does not state the gradient, the run time alone cannot answer the question.

For in-vitro laboratory research use only. All products and information provided are not for human or veterinary use. The compounds sold by Excalibur Peptides are chemical reagents intended solely for laboratory and developmental applications. It is the researcher's responsibility to ensure proper handling, storage, and use of these materials in accordance with established laboratory safety protocols and to independently verify suitability for their specific assay.